SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-18 Cr | ₹83 Cr | ₹-45 Cr | ₹-27 Cr | ₹-18 Cr |
What is the latest Cash Flow from Investing Activities ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-18 Cr |
| Mar2024 | ₹83 Cr |
| Mar2023 | ₹-45 Cr |
| Mar2022 | ₹-27 Cr |
| Mar2017 | ₹-18 Cr |
How is Cash Flow from Investing Activities of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-18 Cr | Negative | |
| Mar2024 | ₹83 Cr | Positive | |
| Mar2023 | ₹-45 Cr | Negative | |
| Mar2022 | ₹-27 Cr | Negative | |
| Mar2017 | ₹-18 Cr | - | |
Compare Cash Flow from Investing Activities of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,454.2 Cr | -1.6% | -6.2% | -23% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,412.0 Cr | -0.4% | 6.4% | 4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,343.0 Cr | -1.5% | -4.9% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,191.0 Cr | -0.7% | 4.8% | 16.6% | Stock Analytics | |
| CIPLA | ₹122,511.0 Cr | -0.5% | 1% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,523.0 Cr | 2.2% | 6.6% | 5.7% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -1.6% |
-6.2% |
-23% |
| SENSEX | 0.7% |
0.9% |
6.1% |
You may also like the below Video Courses